Source: International Congress 2015 – Pulmonary hypertension: novel insights into the biology of the disease
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Balram Neupane (Bharatpur, Nepal), Balram Neupane, Djuro Kosanovic, Christina Vroom, Akylbek Sydykov, Hossein Ardeschir Ghofrani, Norbert Weissmann, Friedrich Grimminger, Werner Seeger, Christiane Herden, Ralph Theo Schermuly. Obesity aggravates monocrotaline–induced pulmonary hypertension in female Zucker rats. Eur Respir J 2015; 46: Suppl. 59, 2430

Member's Comments

No comment yet.

Related content which might interest you: Erythropoietin recapitulates hemodynamic features of hypoxia-induced pulmonary hypertension in mice Source: International Congress 2016 – The nature of pulmonary hypertension Year: 2016 Targeting aquaporin 1 reverses hypoxia-induced pulmonary hypertension in mice Source: International Congress 2016 – The nature of pulmonary hypertension Year: 2016 TRAM-34 ameliorates hypoxia-induced pulmonary arterial hypertension in rats Source: Annual Congress 2013 –Pulmonary circulation: animal models and experimental treatments Year: 2013 Renal denervation reduces pulmonary vascular remodeling in two experimental pulmonary arterial hypertension models Source: International Congress 2015 – Pulmonary hypertension: new treatment insights Year: 2015 Human apyrase (APT102) treatment attenuates the development of severe pulmonary arterial hypertension (PAH) Source: Annual Congress 2013 –Pulmonary circulation: animal models and experimental treatments Year: 2013 Intact serotonin signaling is not required for the development of severe angioproliferative pulmonary hypertension in rats Source: International Congress 2014 – Pathobiology of pulmonary hypertension Year: 2014 Role of survivin in experimental models of pulmonary arterial hypertension Source: International Congress 2016 – Pulmonary hypertension and pulmonary embolism: from the bench to the bedside Year: 2016 Therapeutic potential of DMHCA for pulmonary arterial hypertension (PAH) Source: Annual Congress 2013 –Pulmonary circulation: animal models and experimental treatments Year: 2013 Pulmonary vasoreactivity in spontaneously hypertensive rats - Effects of leptin and endothelin-1 Source: Annual Congress 2013 –Pulmonary circulation: animal models and experimental treatments Year: 2013 Effect of POL6014, a protein epitope mimetic (PEM) neutrophil elastase inhibitor, in a model of monocrotaline (MCT)-induced pulmonary arterial hypertension in rats Source: Annual Congress 2013 –Pulmonary circulation: animal models and experimental treatments Year: 2013 Repeated embolization and fibrinolysis inhibition induce chronic thromboembolic pulmonary hypertension in rabbits Source: Annual Congress 2013 –Pulmonary circulation: chronic thromboembolic pulmonary hypertension, imaging and biomarkers Year: 2013 Reversibility of the monocrotaline pulmonary hypertension rat model Source: Eur Respir J 2013; 42: 553-556 Year: 2013 Expression and function of aquaporin 1 in hypoxia-induced pulmonary hypertension Source: International Congress 2015 – Pulmonary hypertension: promising small molecules Year: 2015 LATE-BREAKING ABSTRACT: Pneumonectomy combined with SU5416: a novel animal model of pulmonary hypertension Source: Annual Congress 2013 –Pulmonary circulation: animal models and experimental treatments Year: 2013 LATE-BREAKING ABSTRACT: KCNK3 dysfunction contributes to the development of pulmonary arterial hypertension – Characterization of Kcnk3 deficient rats Source: International Congress 2016 – Pulmonary hypertension: novel insights Year: 2016 Role of the TrkA receptor in experimental severe pulmonary hypertension Source: International Congress 2015 – Pulmonary hypertension: promising small molecules Year: 2015 Siah2 in pulmonary hypertension and right ventricular hypertrophy Source: Annual Congress 2013 –Pulmonary circulation: animal models and experimental treatments Year: 2013 Formation of typical vascular lesions in a new experimental model of pulmonary arterial hypertension Source: Annual Congress 2013 –Pulmonary circulation: animal models and experimental treatments Year: 2013 Prolonged activity of inhaled treprostinil prodrug nanoparticles in a rat model of pulmonary arterial hypertension Source: International Congress 2014 – Pulmonary hypertension: novel targets and drugs Year: 2014 Immune and inflammatory cell involvement in the pathology of idiopathic pulmonary arterial hypertension Source: Annual Congress 2013 –Pulmonary circulation: basic science Year: 2013